Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Learn more about:
Related Clinical Trial
European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma
Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma
Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
International Pediatric Adrenocortical Tumor Registry
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Structured Evaluation of adRENal Tumors Discovered Incidentally – Prospectively Investigating the Testing Yield
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Possible New Therapy for Advanced Cancer
IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Evaluation of Side Effects of Mitotane
Sunitinib in Refractory Adrenocortical Carcinoma
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma
Cabozantinib in Advanced Adrenocortical Carcinoma
Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
German Adrenocortical Carcinoma Registry
Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma